125 related articles for article (PubMed ID: 9650118)
1. ACE-inhibitors and progression of chronic renal insufficiency: a contribution of Italian clinical research.
Andreucci VE; Gallieni M; Brancaccio D
J Nephrol; 1998; 11(3):105-9. PubMed ID: 9650118
[No Abstract] [Full Text] [Related]
2. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
Pisoni R; Faraone R; Ruggenent P; Remuzzi G
J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
[TBL] [Abstract][Full Text] [Related]
3. [Further evidence for the renoprotective effect of ACE inhibitors: ramipril protects against the progression of chronic renal insufficiency in non-diabetic nephropathy with nephrotic proteinuria].
Mayr M; Dickenmann MJ
Schweiz Med Wochenschr; 2000 Apr; 130(13):491. PubMed ID: 10812646
[No Abstract] [Full Text] [Related]
4. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
Tesar V
Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials in progression of chronic renal failure.
Striker GE; Klahr S
Adv Intern Med; 1997; 42():555-95. PubMed ID: 9048130
[No Abstract] [Full Text] [Related]
6. [ACE inhibitors and AT-II antagonists--do they protect against renal disease?].
Rossing P; Parving HH
Ugeskr Laeger; 2006 Apr; 168(15):1564; author reply1564-5. PubMed ID: 16640990
[No Abstract] [Full Text] [Related]
7. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Cantarovich F; Rangoonwala B
Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
[TBL] [Abstract][Full Text] [Related]
8. [Angiotensin-converting enzyme inhibition and progressing chronic nephropathy].
Kamper AL; Strandgaard S
Ugeskr Laeger; 1997 Nov; 159(48):7121-3. PubMed ID: 9417716
[No Abstract] [Full Text] [Related]
9. [ACE inhibitors and kidney].
Ritz E
Wien Med Wochenschr; 1990 Jan; 140(1-2):18-21. PubMed ID: 2408246
[TBL] [Abstract][Full Text] [Related]
10. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
11. [Comment on the contribution: Barnas, Ursula, Mayer, G.: Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
Pieber TR; Brunner GA
Wien Klin Wochenschr; 1995; 107(14):439-41. PubMed ID: 7668005
[No Abstract] [Full Text] [Related]
12. [Renoprotection and blockade of the renin-angiotensin system: What shall we believe?].
Kamper AL; Feldt-Rasmussen B; Strandgaard S
Ugeskr Laeger; 2006 Apr; 168(15):1563. PubMed ID: 16640988
[No Abstract] [Full Text] [Related]
13. The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design.
Knoll GA; Cantarovitch M; Cole E; Gill J; Gourishankar S; Holland D; Kiberd B; Muirhead N; Prasad R; Tibbles LA; Treleaven D; Fergusson D
Nephrol Dial Transplant; 2008 Jan; 23(1):354-8. PubMed ID: 17848393
[TBL] [Abstract][Full Text] [Related]
14. [Ramipril and new therapeutic possibilities for ACE-inhibitors].
Vespasiani Gentilucci U; Picardi A
Clin Ter; 2000; 151(4):307-8. PubMed ID: 11107682
[No Abstract] [Full Text] [Related]
15. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
Guidi E; Minetti EE; Cozzi MG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC
Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
[TBL] [Abstract][Full Text] [Related]
17. [The ACE inhibitor spirapril in chronic renal failure, hypertension and diabetic nephropathy].
Elliot HL
Ter Arkh; 2000; 72(10):78-82. PubMed ID: 11220886
[TBL] [Abstract][Full Text] [Related]
18. Non-diabetic nephropathies and ACE inhibition.
Pruna A; El Esper N; Makdassi R; Oprisiu R; Fournie A
Lancet; 1999 Nov; 354(9193):1905-6. PubMed ID: 10584749
[No Abstract] [Full Text] [Related]
19. [Kidney failure, proteinuria, and diabetic nephropathy].
Collart F
Rev Med Brux; 2003 Sep; 24(4):A257-62. PubMed ID: 14606290
[TBL] [Abstract][Full Text] [Related]
20. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
Sebeková K; Gazdíková K; Syrová D; Blazícek P; Schinzel R; Heidland A; Spustová V; Dzúrik R
J Hum Hypertens; 2003 Apr; 17(4):265-70. PubMed ID: 12692571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
